Omega Therapeutics, Inc. (OMGA) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/14/24
Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific MeetingsGlobeNewsWire • 10/15/24
Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature CommunicationsGlobeNewsWire • 09/17/24
Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of ResearchGlobeNewsWire • 08/14/24
Omega Therapeutics, Inc. (OMGA) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/06/24
Omega Therapeutics Reports Second Quarter 2024 Financial Results and Highlights Recent Company ProgressGlobeNewsWire • 08/06/24
Omega Therapeutics Announces Election of Richard N. Kender to Board of DirectorsGlobeNewsWire • 06/24/24
Omega Therapeutics Presents New Preclinical Data at ASGCT 2024 Demonstrating Tunable and Durable Upregulation of Gene Expression with Epigenomic ControllersGlobeNewsWire • 05/08/24
Omega Therapeutics, Inc. (OMGA) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/06/24
Omega Therapeutics Reports First Quarter 2024 Financial Results and Highlights Recent Company ProgressGlobeNewsWire • 05/06/24
Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Zacks Investment Research • 04/25/24
Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual MeetingGlobeNewsWire • 04/23/24
Omega Therapeutics (OMGA) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowZacks Investment Research • 04/17/24
Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic ControlGlobeNewsWire • 04/09/24
Omega Therapeutics (OMGA) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 04/03/24
Omega Therapeutics, Inc. (OMGA) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 03/28/24
Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic UpdateGlobeNewsWire • 03/28/24
Omega Therapeutics Announces Two Poster Presentations at the American Association for Cancer Research Annual Meeting 2024GlobeNewsWire • 03/06/24